Is there a role for the ob gene product leptin in essential hypertension?

American Journal of Hypertension

Volumn 11, Issue 11 I, 1998, Pages 1305-1311

  Suter, Paolo M ^a   Locher, Rudolf ^a   Häsler, Erik ^a   Vetter, Wilhelm ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Aldosterone; Blood pressure; Essential hypertension; Leptin; Ob gene product; Obesity; Renin

Indexed keywords

ALDOSTERONE; ANGIOTENSINOGEN; GENE PRODUCT; LEPTIN; NEUROPEPTIDE Y;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GENE EXPRESSION; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; NEUROMODULATION; OBESITY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL;

ADULT; AGED; ANGIOTENSINOGEN; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; LEPTIN; MALE; MIDDLE AGED; OBESITY; PROTEINS; RENIN;

EID: 0031795731     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00162-9     Document Type: Article

References (31)

1. Hsueh W.A., Buchanan T.A. Obesity and hypertension. Endocrin Metabol Clin North Am. 23:1994;405-427.
2. Reaven G.M., Lithell H., Landberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl J Med. 334:1996;374-381.
3. Zhang Y., Proenca R., Maffei M., et al. Positional cloning of the mouse obese gene and its human homologue. Nature. 372:1994;425-432.
4. -1 mice. Science. 269:1995;540-543.
5. Campfield L.A., Smith F.J., Burn P. The OB protein (leptin) pathway - a link between adipose tissue mass and central neural networks. Horm Metab Res. 28:1996;619-632.
6. Cioffi J.A., Shafer A.W., Zupancic T.J., et al. Novel B219/OB receptor isoforms possible role of leptin in hematopoiesis and reproduction . Nature Med. 2:1996;585-588.
7. Barash I.A., Cheung C.C., Weigle D.S., et al. Leptin is a metabolic signal to the reproductive system. Endocrinology. 137:1996;3144-3147.
8. Merabet E., Dagogo-Jack S., Coyne D.W., et al. Increased plasma leptin concentration in end-stage renal disease. J Clin Endocrinol Metab. 82:1997;847-850.
9. Caro J.F., Sinha M.K., Kolaczynski J.W., et al. Leptin the tale of an obesity gene . Diabetes. 45:1996;1455-1462.
10. Grossman E.U., Desprès J.P. Obesity results as a consequence of glucocorticoid induced leptin resistance. Horm Metab Res. 28:1996;744-747.
11. Campfield L.A., Smith F.J., Guisez Y., et al. Recombinant mouse ob protein evidence for a peripheral signal linking adiposity and central neural networks . Science. 269:1995;546-549.
12. Vetter W., Vetter H., Siegenthaler W. Radioimmunoassay for aldosterone without chromatography. Acta Endocrinol Copenh. 74:1973;548-557.
13. Rosenbaum M., Nicolson M., Hirsch J., et al. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol. 81:1996;3424-3427.
14. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 153:1993;154-183.
15. Kennedy A., Gettys T.W., Watson P., et al. The metabolic significance of leptin in humans gender based differences in relationship to adiposity, insulin sensitivity, and energy expenditure . J Clin Endocrinol Metabol. 82:1997;1293-1300.
16. Tuominen J.A., Ebeling P., Laquier F.W., et al. Serum leptin concentration and fuel homeostasis in healthy man. Eur J Clin Invest. 27:1997;206-211.
17. Reaven G.M. Role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
18. Sealey J.E., Laragh J.H. The renin angiotensin aldosterone system for normal regulation of blood pressure and sodium and potassium homeostasis. Laragh J.H., Brunner B. Hypertension Pathophysiology, Diagnosis, and Management . 1990;1298-1317 Raven Press, New York.
19. Saye J.A., Ragsdale N.V., Carrey R.M., Peach M.J. Localisation of angiotensin peptid forming enzymes of 3T3 F44 2A adipocytes. Am J Physiol. 264:(C):1993;1570-1576.
20. Hopkins P.M., Hunt S.C., Wu L.L., et al. Hypertension, dyslipidemia and insulin resistance links in a chain or spokes on a view? Curr Opin Lipidol. 7:1996;241-251.
21. Frederich R.C., Kahn B.B., Peach M.J., Flier J.S. Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension. 19:1992;339-344.
22. Tamura K., Umemura S., Iwamoto T., et al. Molecular mechanism of adipogenic activation of the angiotensinogene gene. Hypertension. 23:1994;364-368.
23. Moustaid N., Jones B.H. Regulation of expression of the angiotensinogen gene in adipocytes. FASEB J. 11:1997;A352. (abstract 1043).
24. Zorad S., Fickova M., Zelezna B., et al. The role of angiotensin II and its receptors in regulation of adipose tissue metabolism and cellularity. Gen Physiol Biophys. 14:1995;383-391.
25. Jeunemaitre X., Soubrier F., Kotelevtsev Y.V., et al. Molecular basis of human hypertension role of angiotensinogen . Cell. 71:1992;169-180.
26. Weidmann P., Courten M., Böhler L.M., Shore F. The pathogenesis of hypertension and obese subjects. Drug. 46:1993;197-209.
27. Campfield L.A., Smith F.J., Burn P. OB protein a hormonal controller of central neural networks mediating behavioral, metabolic and neuroendocrine responses . Endocrinol Metab. 4:1997;81-102.
28. Wolf G. Neuropeptides responding to leptin. Nutr Reviews. 55:1997;85-88.
29. Walker P., Grouzmann E., Burnier M., Waeber B. The role of neuropeptide Y in cardiovascular regulation. TIPS. 12:1991;111-115.
30. Rohner-Jeanrenaud F., Cusin I., Sainsbury A., et al. The loop system between neuropeptide Y and leptin in normal and obese rodents. Horm Metabol Res. 28:1996;642-648.
31. Shek Ew, Brands M.W., Hall J.E. Chronic leptin infusion increases arterial blood pressure. Hypertension. 31:(part 1, supplement):1998;S409-S414.